The Dried Blood Spot Collection Cards Market Size is valued at USD 377.9 million in 2023 and is predicted to reach USD 537.8 million by the year 2031 at a 4.7% CAGR during the forecast period for 2024-2031.
Dried Blood Spot (DBS) Collection Cards are specifically designed cards utilized for the collection and preservation of tiny blood samples for diagnostic tests and research purposes. Blood is commonly obtained through a finger puncture and then absorbed onto the card, where it subsequently dries and can be stored for future examination. The growing initiatives from government bodies, private-public partnerships, and collaborative efforts to enhance utilization and raise awareness about diagnostic products are poised to stimulate market demand in the upcoming years.
Additionally, this technology allows first responders to collect a simple finger-prick specimen sample at a crime scene, such as in cases involving drug-facilitated or sexual assault, eliminating the need to wait for subsequent collection at the hospital after the victim has been admitted. This not only saves significant time but also reduces additional effort. The increasing benefits and ongoing research in DBS testing for diagnostic purposes are expected to drive market growth in the forecast period. Moreover, the World Health Organization (WHO) recently endorsed DBS for diagnosing hepatitis B & C and HIV due to its advantages in blood collection and transport.
However, a key challenge hindering market growth is the contamination issues associated with DBS collection cards. There have been instances where the use of these cards led to problems such as cross-contamination and exposure of samples for pathologists and clinicians handling specimens.
Competitive Landscape
Some Major Key Players In The Dried Blood Spot Collection Cards Market:
- QIAGEN
- PerkinElmer
- Roche
- Shimadzu Corporation
- Ahlstrom-Munksjö
- Pall Corporation
- Eastern Business Forms, Inc
- Archimed Life Science Gmbh
- Centogene N.V.
- Other Market Players
Market Segmentation:
The global market of dried blood spot collection cards is categorized on the basis of application card type and end users. The market is segmented by material type into Cotton & Cellulose, Fiber-based, and Others. Applications include Newborn Screening, Infectious Disease Testing, Therapeutic Drug Monitoring, Forensic Testing, CRO/Research and Other Applications. End users comprise Hospitals and Clinics, Diagnostic Laboratories, Research Institutes, and Others. Card types include Whatman 903, Ahlstrom 226, FTA, and Others.
The Whatman 903 Segment Is Accounted As A Major Contributor In The Dried Blood Spot Collection Cards Market.
The Whatman 903 segment took the lead in the market with a major share and is projected to exhibit the swiftest Compound Annual Growth Rate (CAGR) throughout the forecast period. Whatman paper, a specific filter paper extensively used in qualitative analysis, characterizes this segment. Among various paper types, the Whatman 903 filter paper stands out as an FDA-approved in vitro Class II medical device that is widely employed in newborn screening programs globally despite its relatively higher cost as a ready-to-use card. Additionally, they boast high wet strength, facilitating the efficient removal of significant impurities.
The Newborn Screening Segment Witnessed Growth At A Rapid Rate.
Newborn screening involves a series of laboratory tests conducted on newborn infants to identify specific genetic diseases. This testing is conducted using a blood sample obtained from a heel prick, typically when the baby is between two and three days old. The growing demand for newborn screening in developed countries is a significant driver of segment growth. For example, in countries like the United States, newborn screening is mandatory for a specified group of genetic disorders, though the exact list varies from state to state. These tests are focused on conditions where early detection is crucial for effective treatment or prevention of disease. Detecting these conditions early enables prompt initiation of various treatments and interventions during the newborn's critical early stages of life, potentially leading to improved health outcomes and the prevention of severe, irreversible disabilities.
In The Region, The North American Dried Blood Spot Collection Cards Market Holds A Significant Revenue Share.
The North American dried blood spot collection cards market is expected to report the maximum market share in terms of revenue in the near future.]The leading market position is primarily due to a multitude of manufacturers and established childcare facilities. Public organizations' guidelines on DBS procedures guarantee superior quality products, fostering increased trust among researchers and clinicians. This enhances overall market demand throughout North America. The Asia-Pacific market for dried blood spot collection cards is projected to experience the highest CAGR in the coming years. This growth can be attributed to the sizable population base in countries like China & India.
Additionally, rising awareness about newborn screening is anticipated to influence the Asia-Pacific market positively by 2030. Furthermore, the increasing adoption of advanced laboratory techniques, including DBS collection cards, for swift diagnosis and investigations is a major driver of market expansion. The introduction of innovative DBS collection cards also plays a important role in driving this growth.
Dried Blood Spot Collection Cards Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 377.9 Mn |
|
Revenue Forecast In 2031 |
USD 537.8 Mn |
|
Growth Rate CAGR |
CAGR of 4.7% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Mn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Application, Card Type, And End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea |
|
Competitive Landscape |
QIAGEN, PerkinElmer, Roche, Shimadzu Corporation, Ahlstrom-Munksjö, Pall Corporation, Eastern Business Forms, Inc, Archimed Life Science Gmbh, Centogene N.V. and others |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
